Promoter Ghanshyam Pansuriya disclosed acquisition of 14,000 equity shares in Aptus Pharma Limited via off-market inter-se transfer.
His total holding increased from 5.10% to 5.31% of the company's voting capital through this transaction.
The disclosure was made under SEBI SAST Regulation 29(2) following the acquisition on May 11, 2026.
Aptus Pharma Limited is listed on BSE SME with an equity capital of 68.60 lakh shares of ₹10 each.